Journal
Molecular Therapy
Publication Date
2016
Volume
24
Issue
2
Document Type
Open Access Publication
DOI
10.1038/mt.2015.189
Rights and Permissions
Ponder KP, et al. Evaluation of AAV-mediated Gene Therapy for Central Nervous System Disease in Canine Mucopolysaccharidosis VII. Mol Ther. 2016 Feb;24(2):206-16. doi: 10.1038/mt.2015.189. This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0
Recommended Citation
Ponder, Katherine P. and et al, "Evaluation of AAV-mediated gene therapy for central nervous system disease in canine mucopolysaccharidosis VII." Molecular Therapy. 24, 2. (2016).
https://digitalcommons.wustl.edu/open_access_pubs/5516
Supplementary Material
